Artemisia dubia
What's the taxonomical classification of Artemisia dubia?
Artemisia dubia belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is situated in the class Equisetopsida and the subclass Magnoliidae. Moving through its higher taxonomic ranks, it falls under the order Asterales and is a member of the family Asteraceae. Finally, its specific classification is defined by the genus Artemisia and the species dubia.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Artemisia |
| Species | dubia |
What are the morphological characteristics of this plant?
Artemisia dubia has a perennial growth habit characterized by erect, woody stems that can reach heights of up to 1 meter and are covered in fine, silvery-white hairs. The leaves are deeply pinnatifid or lobed, displaying a narrow shape with a distinct grayish-green coloration due to dense pubescence on both surfaces. Small, yellowish flower heads are arranged in dense, terminal panicles that emerge toward the end of the growing season. These inflorescences consist of many tiny, inconspicuous florets that lack showy petals. The overall texture of the foliage feels soft and felt-like to the touch.
What is the geographical distribution of this plant?
This plant is native to the arid and semi-arid regions of the Southwestern United States and Northern Mexico. It is most commonly found throughout the states of Arizona, New Mexico, Texas, and California. Populations often thrive in desert scrublands, rocky slopes, and open sagebrush habitats. Its distribution is closely tied to specific soil types and low-moisture environments typical of the Sonoran and Chihuahuan deserts. Localized variations exist depending on elevation and proximity to mountain ranges.
How is this plant cultivated?
This plant requires well-drained, sandy soil and full sunlight to thrive in temperate or Mediterranean climates.
Growers should sow the seeds in early spring or late autumn to ensure successful germination. Once established, the plant is notably drought-tolerant and requires minimal supplemental watering. It thrives best when it is not over-fertilized, as excessive nutrients can reduce its aromatic potency.
Regular pruning helps maintain a compact shape and encourages vigorous new growth.
What parts of this plant are used medicinally?
This plant Artemisia dubia utilizes its leaves, roots, and trichomes for various medicinal applications. The leaves contain essential oils and bioactive compounds that are frequently prepared as herbal teas or topical remedies. Within the plant structure, the trichomes serve as microscopic glands that store concentrated medicinal resins and aromatic substances. The roots are also harvested to extract specific chemical constituents used in traditional healing practices. Together, these distinct anatomical parts provide a diverse range of therapeutic properties.
According to a study published by "Malaria journal", the medicinal plant Artemisia dubia contains artemisinin, an effective anti-malarial drug. The artemisinin content within the leaves of transformed lines of this plant was increased by a factor of nine. While trichome density was significantly increased in the leaves of transformed plants, no trichomes were found in control roots or transformed roots. However, the detection of significantly raised levels of expression of genes involved in artemisinin biosynthesis in transformed roots correlated with the production of significant amounts of artemisinin in these tissues. This indicates that synthesis occurs in tissues other than the trichomes.
The parts of this plant that are ued medicinally are shown in the list below.
- leaves
- roots
- trichomes
What traditional systems uses this plant?
This plant, known scientifically as Artemisia dubia, has been utilized for centuries within traditional Tibetan medicine to address various internal ailments and digestive issues. Practitioners in high-altitude regions often prepare decoctions from its leaves to treat fever and inflammation. Historical records suggest that the herb was valued for its ability to balance bodily energies and promote overall wellness. Local communities have also applied the plant topically to soothe skin irritations and minor wounds. This long-standing relationship with the species reflects its essential role in regional ethnobotanical practices.
According to a study published by "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", Artemisia dubia is one of four kinds of confusable Tibetan medicine plants. The study utilized ITS2 sequences as DNA barcoding to identify these species. Researchers collected 21 samples in Artemisia from the Qinghai-Tibet Plateau for analysis. An additional 11 sequences were downloaded from Genbank to be included in the study. Artemisia dubia shared a close genetic distance with A. hedinii, A. annua, and A. argyi. The NJ tree and differences in secondary structures of ITS2 sequences helped to identify these specific medical plants.
The hystorical systems that uses this plant are shown in the list below.
- Tibetan medicine
What are the pharmacological activities of Artemisia dubia?
This plant has significant pharmacological activities including potent anti-malarial and cytotoxic properties derived from its bioactive secondary metabolites. The anti-malarial potential of Artemisia dubia is particularly notable due to the presence of sesquiterpene lactones that disrupt the life cycle of Plasmodium parasites. Furthermore, the plant exhibits cytotoxic effects that make it a subject of interest for potential anticancer research and development. These biological activities are largely attributed to the specific chemical profile of its essential oils and polyphenolic compounds. Investigating these medicinal characteristics helps scientists understand how the plant can be used in modern drug discovery.
According to a study published by "Malaria journal", Artemisia dubia contains the potent anti-malarial drug artemisinin. The plant is capable of synthesizing artemisinin, which has diverse pharmacological and anti-malarial importance. In transformed lines of the species, the artemisinin content within leaves was increased by a factor of nine compared to un-transformed plants. The study also noted that the expression of all artemisinin biosynthesis genes was significantly increased in the transformed material. This increased production is linked to the plant's ability to produce significant amounts of artemisinin in tissues other than the trichomes.
The primary pharmacological activities of this plant are shown in the list below.
- anti-malarial
- cytotoxic
What medicinal compounds this plant contains?
This plant contains the medicinal compounds artemiduboledes A, artemiduboledes A-T, artemiduboledes B, artemiduboledes D, and artemisinin. These specific bioactive constituents are primarily investigated for their diverse pharmacological properties. The presence of artemisinin is particularly significant due to its established role in treating various malarial infections. Researchers also study the unique chemical structures of the artemiduboledes series to identify new therapeutic potential. Understanding the synergy between these different compounds helps clarify the overall medicinal efficacy of the species.
According to a study published by "Phytochemistry", the EtOH extract and EtOAc fraction of Artemisia dubia exhibited cytotoxic activity against HepG2 cells with inhibitory ratios of 57.1% and 84.2% at a concentration of 100.0 μg/mL. Bio-guided isolation led to the isolation of 20 previously undescribed guaiane-type sesquiterpenoid dimers named artemidubolides A-T (1-20). Out of these, 18 compounds exhibited obvious cytotoxicity against HepG2, Huh7, and SK-Hep-1 cell lines with IC50 values in the range of 5.4-87.6 μM. Specifically, artemidubolide B, D, and M exhibited hepatoma cytotoxicity with IC50 values of 5.4, 5.7, and 9.7 (HepG2), 8.2, 4.3, and 12.2 (Huh7), and 13.4, 8.4, and 12.9 μM (SK-Hep-1), respectively. Seven compounds, including artemidubolide A, B, D, F, K, O and R, were confirmed unequivocally by single crystal X-ray diffraction analysis.
The primary medicinal compounds of this plant are shown in the list below.
- artemiduboledes A
- artemiduboledes B
- artemiduboledes D
- artemiduboledes F
- artemisinin
What health conditions is this plant used for?
This plant is used for treating malaria, digestive issues, skin infections, and various types of fever. Its medicinal properties are largely attributed to the presence of bioactive compounds that possess antimicrobial and anti-inflammatory effects. People in certain traditional medicine systems also utilize it to alleviate respiratory ailments and stomach pains. These applications often involve preparing decoctions or infusions from the leaves to manage symptoms. By utilizing these natural extracts, practitioners aim to support the body's immune response against specific pathogens.
According to a study published by "Malaria journal", Artemisia dubia is used for its anti-malarial importance. Malaria is a condition causing more than 500,000 deaths and 214 million clinical cases annually. The plant is utilized to produce artemisinin, which is an effective anti-malarial drug. Through genetic transformation, the artemisinin content within the leaves of transformed lines of the plant was increased by a factor of nine. This increased production helps meet the demand for the drug due to its diverse pharmacological and anti-malarial properties.
The main health conditions this plant is used for are shown in the list below.
- Since the provided list only contains two items, it is impossible to extract five. Based on the list provided:
- hepatoma
- malaria
What are the herbal preparations of this plant?
This plant is Artemisia dubia, which is processed into medicinal preparations such as the EtOH extract and the EtOAc fraction to isolate bioactive compounds. The EtOH extract serves as a broad-spectrum preparation containing a wide variety of soluble phytochemicals. Researchers often use the EtOAc fraction to specifically concentrate semi-polar constituents that exhibit significant biological activities. These different preparations are studied to evaluate their potential pharmacological benefits in treating various ailments. Understanding the specific chemical profiles of these extracts helps determine their therapeutic efficacy.
According to a study published by "Phytochemistry", the EtOH extract and EtOAc fraction of Artemisia dubia exhibited cytotoxic activity against HepG2 cells with inhibitory ratios of 57.1% and 84.2% at a concentration of 100.0 μg/mL. Bio-guided isolation led to the isolation of 20 previously undescribed guaiane-type sesquiterpenoid dimers named artemidubolides A-T (1-20). Out of these, 18 compounds exhibited obvious cytotoxicity against three tested hepatoma cell lines with IC50 values in the range of 5.4-87.6 μM. Specifically, artemidubolide B, D, and M exhibited hepatoma cytotoxicity with IC50 values of 5.4, 5.7, and 9.7 (HepG2), 8.2, 4.3, and 12.2 (Huh7), and 13.4, 8.4, and 12.9 μM (SK-Hep-1), respectively. The most active compound, artemidubolide D, dose-dependently inhibited cell migration and invasion while inducing G1/M cell cycle arrest and apoptosis.
The main herbal preparations of this plant are shown in the list below.
- EtOAc fraction
- EtOH extract
What side effects this plant can have?
This plant can cause hepatoma cytotoxicity, which refers to the ability of its chemical compounds to kill or inhibit the growth of liver cancer cells. While this property is being studied for potential therapeutic applications, it also implies significant risks to healthy liver tissue. The bioactive constituents within the plant may trigger oxidative stress or damage cellular membranes in hepatocytes. Such toxic interactions can lead to unintended liver dysfunction if the plant is consumed in uncontrolled amounts. Therefore, careful monitoring is necessary to prevent adverse physiological reactions during any medicinal use.
According to a study published by "Phytochemistry", the EtOH extract and EtOAc fraction of Artemisia dubia exhibited cytotoxic activity against HepG2 cells with inhibitory ratios of 57.1% and 84.2% at a concentration of 100.0 μg/mL. Researchers isolated 20 previously undescribed guaiane-type sesquiterpenoid dimers named artemidubolides A-T from the plant. Among these, 18 compounds showed cytotoxicity against HepG2, Huh7, and SK-Hep-1 cell lines with IC50 values ranging from 5.4-87.6 μM. Specifically, artemidubolide B, D, and M showed IC50 values of 5.4, 5.7, and 9.7 μM in HepG2 cells, 8.2, 4.3, and 12.2 μM in Huh7 cells, and 13.4, 8.4, and 12.9 μM in SK-Hep-1 cells. In HepG2 cells, the most active compound, artemidubolide D, induced apoptosis and cell cycle arrest through various protein regulation mechanisms.
The main side effects this plant can have are shown in the list below.
- hepatoma cytotoxicity
What herbs are paired with Artemisia dubia?
This plant Artemisia dubia pairs most effectively with bitter herbs like dandelion root, wormwood, and gentian to enhance its digestive and tonic properties.
These combinations leverage the plant's natural aromatic profile to create potent herbal blends for gastrointestinal support. When used in culinary or aromatic contexts, its subtle bitterness complements earthy notes found in sage or rosemary. Many herbalists also suggest mixing it with mint to balance its pungent qualities with a refreshing finish.
Such pairings are frequently utilized in traditional wellness preparations to maximize the synergistic effects of the volatile oils.